Evonik's Global Showcase Meets a New Dividend Reality

Evonik showcases growth in cosmetics, RNA tech, and EV materials while cutting its dividend to 1.00 euro per share and shifting to a more flexible payout policy for future investments.

While Evonik's stock has surged nearly 30% since the start of the year, the company is now presenting investors with a complex picture of global innovation paired with a significant cut to its shareholder payout. The German specialty chemicals giant is simultaneously staging high-profile demonstrations of its growth engines across three continents, even as it prepares to implement a new, more flexible dividend policy that will initially mean less cash for investors.

In Paris, the company is targeting the beauty industry at the in-cosmetics Global trade show, which expects over 13,000 professional visitors from Europe and the US. Under the theme "Sky Garden of Tomorrow," Evonik is unveiling new products like SPHINOX Vively, a designer sphingolipid for skin rejuvenation, and emphasizing its shift toward glycolipid bio-tensides and ecologically optimized ingredients.

Parallel to this, the company is reinforcing its leadership in RNA therapeutics with a specialized workshop on lipid nanoparticles in Cambridge, Massachusetts. A third strategic front is in Shanghai, where Evonik is showcasing high-performance polymers for electric vehicle batteries, with a focus on lightweight solutions developed at its own research center.

This global offensive is built on a stable operational foundation. For 2025, Evonik reported adjusted EBITDA of 1.87 billion euros, hitting its own forecast precisely. Net income improved to 265 million euros from 222 million. For the current year, management continues to target an operating result between 1.7 and 2.0 billion euros.

The financial landscape for shareholders, however, is shifting. The board has proposed a dividend of 1.00 euro per share for the past financial year, a clear reduction from the 1.17 euros paid previously. At recent price levels, this still translates to a dividend yield of approximately seven percent. This proposal is set for a final vote at the Annual General Meeting on June 3, 2026.

That meeting will also ratify a new long-term payout mechanism. Starting in 2026, Evonik plans to distribute 40 to 60 percent of its adjusted net income to shareholders. Management aims to secure greater financial flexibility for future investments with this move. Analysts at Jefferies project an exceptionally high dividend coverage ratio of over 200 percent beginning in 2027, suggesting strong future payout potential.

Market reaction has been muted in the short term. The share price recently declined by 2.66 percent to 16.85 euros, with an RSI reading of 32.5 indicating a slightly oversold condition in the near term. Despite this, the stock remains comfortably above its 50-day moving average of 15.16 euros.

The company's calendar remains packed. Following the Paris event, appearances are scheduled for the China Feed Expo and the Chinaplas fair in Shanghai in April. The next major milestone for investors will be the release of first-quarter results in May. Alongside operational figures, progress on the planned sale of the remaining Performance Materials business is expected to be a key driver for the stock's direction.

Concurrently, a strict efficiency program continues, with up to 2,000 positions slated for elimination. This restructuring, combined with its targeted growth in specialties, frames Evonik's strategy as it balances immediate shareholder returns with long-term strategic investment.